angiotensin-iii and 2-3-naphthalenedicarboxaldehyde

angiotensin-iii has been researched along with 2-3-naphthalenedicarboxaldehyde* in 1 studies

Other Studies

1 other study(ies) available for angiotensin-iii and 2-3-naphthalenedicarboxaldehyde

Article	Year
Determination of endogenous peptides with in vitro ACE inhibitory activity in normotensive human plasma by the fluorometric HPLC method. Bioscience, biotechnology, and biochemistry, 1997, Volume: 61, Issue:6 An in vitro degradation test of angiotensin (ANG) II or III in normotensive supine human plasma from 9 healthy male subjects confirmed the production of smaller ANG metabolites with angiotensin I-converting enzyme inhibitory activity. These metabolites were identified as ANG (3-8), ANG (5-8), and ANG (3-4), whose respective peptide concentrations were determined by our proposed naphthalene-2,3-dialdehyde (NDA)-HPLC method to be 64 +/- 9, 39 +/- 5, 176 +/- 22, and 197 +/- 35 fmol/ml of plasma. Topics: Adult; Angiotensin II; Angiotensin III; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Chromatography, High Pressure Liquid; Humans; In Vitro Techniques; Indicators and Reagents; Male; Naphthalenes; Peptides; Radioimmunoassay; Spectrometry, Fluorescence; Supine Position	1997

Article

Year

Determination of endogenous peptides with in vitro ACE inhibitory activity in normotensive human plasma by the fluorometric HPLC method.

Bioscience, biotechnology, and biochemistry, 1997, Volume: 61, Issue:6

An in vitro degradation test of angiotensin (ANG) II or III in normotensive supine human plasma from 9 healthy male subjects confirmed the production of smaller ANG metabolites with angiotensin I-converting enzyme inhibitory activity. These metabolites were identified as ANG (3-8), ANG (5-8), and ANG (3-4), whose respective peptide concentrations were determined by our proposed naphthalene-2,3-dialdehyde (NDA)-HPLC method to be 64 +/- 9, 39 +/- 5, 176 +/- 22, and 197 +/- 35 fmol/ml of plasma.

Topics: Adult; Angiotensin II; Angiotensin III; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Chromatography, High Pressure Liquid; Humans; In Vitro Techniques; Indicators and Reagents; Male; Naphthalenes; Peptides; Radioimmunoassay; Spectrometry, Fluorescence; Supine Position

1997